| Hans-Günter Meyer-Thompson | Neue Psychoaktive Substanzen
The Dark Side of "Smart Drugs": Cognitive Enhancement vs. Clinical Concerns.
The Dark Side of "Smart Drugs": Cognitive Enhancement vs. Clinical Concerns.
Ingegneri M, Smeriglio E, Zebbiche Y, Cornara L, Visalli L, Smeriglio A, Trombetta D.
Toxics. 2025 Mar 26;13(4):247. doi: 10.3390/toxics13040247. PMID: 40278563; PMCID: PMC12031634.